BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 23335566)

  • 1. Clinical developments of chemotherapeutic nanomedicines: polymers and liposomes for delivery of camptothecins and platinum (II) drugs.
    Kieler-Ferguson HM; Fréchet JM; Szoka FC
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2013; 5(2):130-8. PubMed ID: 23335566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liposomal drug delivery systems: from concept to clinical applications.
    Allen TM; Cullis PR
    Adv Drug Deliv Rev; 2013 Jan; 65(1):36-48. PubMed ID: 23036225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual Stable Nanomedicines Prepared by Cisplatin-Crosslinked Camptothecin Prodrug Micelles for Effective Drug Delivery.
    Li Y; Lu H; Liang S; Xu S
    ACS Appl Mater Interfaces; 2019 Jun; 11(23):20649-20659. PubMed ID: 31117440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer nanomedicines: so many papers and so few drugs!
    Venditto VJ; Szoka FC
    Adv Drug Deliv Rev; 2013 Jan; 65(1):80-8. PubMed ID: 23036224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved pharmacological profile of the lipophilic antitumor dichloro-(N-dodecyl)-propanediamine-platinum(II) complex after incorporation into pegylated liposomes.
    Silva H; Silva AC; Lemos FO; Monte-Neto RL; Fontes AP; Lopes MT; Frézard F
    Anticancer Drugs; 2013 Feb; 24(2):131-9. PubMed ID: 23011234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liposomal nanomedicine for breast cancer therapy.
    Paliwal SR; Paliwal R; Agrawal GP; Vyas SP
    Nanomedicine (Lond); 2011 Aug; 6(6):1085-100. PubMed ID: 21955078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liposomal nanomedicines.
    Fenske DB; Cullis PR
    Expert Opin Drug Deliv; 2008 Jan; 5(1):25-44. PubMed ID: 18095927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Designing polymer conjugates as lysosomotropic nanomedicines.
    Duncan R
    Biochem Soc Trans; 2007 Feb; 35(Pt 1):56-60. PubMed ID: 17233601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymeric drug delivery of platinum-based anticancer agents.
    Haxton KJ; Burt HM
    J Pharm Sci; 2009 Jul; 98(7):2299-316. PubMed ID: 19009590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liposomal nanomedicines in the treatment of prostate cancer.
    Kroon J; Metselaar JM; Storm G; van der Pluijm G
    Cancer Treat Rev; 2014 May; 40(4):578-84. PubMed ID: 24216226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination therapy: opportunities and challenges for polymer-drug conjugates as anticancer nanomedicines.
    Greco F; Vicent MJ
    Adv Drug Deliv Rev; 2009 Nov; 61(13):1203-13. PubMed ID: 19699247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug carriers for the delivery of therapeutic peptides.
    Du AW; Stenzel MH
    Biomacromolecules; 2014 Apr; 15(4):1097-114. PubMed ID: 24661025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanomedicines based drug delivery systems for anti-cancer targeting and treatment.
    Jain V; Jain S; Mahajan SC
    Curr Drug Deliv; 2015; 12(2):177-91. PubMed ID: 25146439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Camptothecin in sterically stabilized phospholipid micelles: a novel nanomedicine.
    Koo OM; Rubinstein I; Onyuksel H
    Nanomedicine; 2005 Mar; 1(1):77-84. PubMed ID: 17292061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delivery of cisplatin from Pluronic co-polymer systems: liposome inclusion and alginate coupling.
    Fang JY; Hsu SH; Leu YL; Hu JW
    J Biomater Sci Polym Ed; 2009; 20(7-8):1031-47. PubMed ID: 19454167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A tumor pH-responsive complex: carboxyl-modified hyperbranched polyether and cis-dichlorodiammineplatinum(II).
    Xia Y; Wang Y; Wang Y; Tu C; Qiu F; Zhu L; Su Y; Yan D; Zhu B; Zhu X
    Colloids Surf B Biointerfaces; 2011 Dec; 88(2):674-81. PubMed ID: 21872454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymer-protein and polymer-drug conjugates in cancer therapy.
    Thanou M; Duncan R
    Curr Opin Investig Drugs; 2003 Jun; 4(6):701-9. PubMed ID: 12901229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumor efficacy of dexamethasone-loaded core-crosslinked polymeric micelles.
    Coimbra M; Rijcken CJ; Stigter M; Hennink WE; Storm G; Schiffelers RM
    J Control Release; 2012 Nov; 163(3):361-7. PubMed ID: 23041274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-tumor efficacy of polymer-platinum(II) complex micelles fabricated from folate conjugated PEG-graft-α,β-poly [(N-amino acidyl)-aspartamide] and cis-dichlorodiammine platinum(II) in tumor-bearing mice.
    Xue Y; Tang X; Huang J; Zhang X; Yu J; Zhang Y; Gui S
    Colloids Surf B Biointerfaces; 2011 Jul; 85(2):280-8. PubMed ID: 21435846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biodegradable polymer-mediated intratumoral delivery of cisplatin for treatment of human head and neck squamous cell carcinoma in a chimeric mouse model.
    Chen FA; Kuriakose MA; Zhou MX; DeLacure MD; Dunn RL
    Head Neck; 2003 Jul; 25(7):554-60. PubMed ID: 12808659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.